Bio Wellness 444 sold Silver Bullet and Silver D douches as unapproved new drugs for vaginal infections.
What happened
On March 10, 2025, FDA reviewed the company’s product labeling, website, and Instagram and found the douche products promoted with claims to treat bacterial vaginosis and yeast infections. FDA said the colloidal silver-containing products are drugs and are unapproved new drugs because no FDA-approved application is in effect.
What FDA found
The products are drugs because their labeling says they treat vaginal infections and affect the body.
FD&C Act sections 201(g)(1)(B) and (C), 21 U.S.C. 321(g)(1)(B) and (C)The products are unapproved new drugs because they are colloidal silver OTC drugs promoted for disease treatment and have no FDA-approved application.
FD&C Act section 505(a), 21 U.S.C. 355(a); 21 CFR 310.548(b)The company introduced or delivered the products into interstate commerce without the required approval.
FD&C Act section 301(d), 21 U.S.C. 331(d)
What FDA wants
FDA asks the company to notify it in writing within 15 working days of the steps taken to correct the violations, including an explanation and supporting documentation. If correction cannot be completed in that time, the company must state why and give a completion date.
Who should pay attention
- online sellers of colloidal silver douche products
- brands making infection-treatment claims for OTC douches
- retailers and social media sellers listing unapproved drug products
This is a summary. Read the original letter on fda.gov.